Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Eikon Therapeutics, Inc.: Filed an amended and restated certificate of incorporation effective immediately prior to closing of IPO (effective 2026-02-06).
- Change
- charter amendment
- Effective
- 2026-02-06
Exact text from the filing
In connection with the closing of the initial public offering (the “IPO”) of shares of common stock of Eikon Therapeutics, Inc. (the “Company”) on February 6, 2026, the Company filed an amended and restated certificate of incorporation (the “Restated Certificate”) with the Secretary of State of the State of Delaware.
View on SEC.gov
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
Eikon Therapeutics, Inc.: Adopted amended and restated bylaws effective as of February 6, 2026, in connection with the closing of the IPO (effective 2026-02-06).
- Change
- bylaw amendment
- Effective
- 2026-02-06
Exact text from the filing
Effective as of February 6, 2026, the Company adopted amended and restated bylaws (the “Restated Bylaws”) in connection with the closing of the IPO.
View on SEC.gov